Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab
Clinical trial NCT05002517 · UNKNOWN
Trial details
- NCT number
- NCT05002517
- Sponsor
- Biogipuzkoa Health Research Institute
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2021-07-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.